Arcellx President Sells $10M Worth of Shares After Acquisition Announcement

Transaction worth based connected SEC Form 4 weighted mean acquisition terms ($113.92); post-transaction worth based connected Feb. 27, 2026 marketplace adjacent ($113.79).

• How does this transaction comparison to Elghandour's erstwhile merchantability activity?
  This merchantability of 89,916 shares is notably larger than his humanities median merchantability size of 38,300 shares since January 2025.

• What interaction does the merchantability person connected the insider's ownership profile?
  Following the sale, Elghandour retains 276,051 shares successful nonstop ownership and maintains 416,500 shares indirectly done a spousal trust, resulting successful continued worldly vulnerability to Arcellx equity.

*Price and 1-year show are calculated utilizing Feb. 28, 2026, arsenic the notation date.

Arcellx, Inc. is simply a clinical-stage biotechnology institution specializing successful innovative immunotherapies for crab and different incurable diseases. The institution chiefly works with oncology healthcare providers and patients with difficult-to-treat cancers crossed the United States and prime planetary markets.

Although ACLX stock prices person soared, the banal volition soon beryllium delisted, arsenic connected Feb. 23, 2026, the institution announced that it would beryllium acquired by Gilead Sciences (NASDAQ:GILD), different planetary biopharmaceutical company. While determination is nary existent expected day for the transaction to beryllium finalized, the acquisition is estimated to beryllium worthy $7.8 billion, with Gilead purchasing Arcellx astatine $115 per stock and a contingent worth close of $5 per share.

The immunotherapy supplier besides precocious achieved a breakthrough with 1 of its apical clinical-stage projects, advancing its aggregate myeloma attraction to Phase 2 development. Another of Arcellx’s biggest developments is simply a humor crab immunotherapy awaiting FDA approval, with a determination expected by December 2026.

If the attraction is proven successful, it would beryllium a large merchandise successful the healthcare abstraction and a important gross generator for Arcellx. However, with the merger connected the way, it’s hard to accidental however agelong investors person to commercialized shares earlier the institution is delisted.